Allan Jonathan Insider Trading Activity

Corporate InsiderGENERAL COUNSEL & CORP SEC · CIK 1966716

24

Total trades

$2.1M

Total volume

Mar 20, 2026

Last activity

STOK

Stoke Therapeutics, Inc.

Allan Jonathan has been net-selling over the last 12 months with 0 purchases and 24 sales across 1 company.

STOK is the most-traded position with 24 trades. The largest single transaction was a sale of STOK for $300K on Sep 2, 2025.

Performance Scorecard

Forward stock performance after each transaction by Allan Jonathan. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.

PERIODAVG BUY RETURNAVG SELL AVOIDEDSUCCESS RATETRADES
30 days-11.9%0%24
90 days-16.1%29%24
120 days-15.9%29%24

Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.

Price & Trades

Pro: Trade Markers

STOK · Stoke Therapeutics, Inc.

🔒 Subscribe to see trade entries

Pro members see exactly when Allan Jonathan bought and sold STOK.

Upgrade to Pro

Recent Trades

DATETICKERTYPESHARESPRICEVALUEΔ OWNEDROLEFILING
Mar 20, 2026
STOKSell8,692$33.64$292K−30.1%GENERAL COUNSEL & CORP SEC
Mar 20, 2026
STOKSell601$34.41$21K−3.0%GENERAL COUNSEL & CORP SEC
Mar 18, 2026
STOKSell4,222$31.28$132K−12.6%GENERAL COUNSEL & CORP SEC
Mar 18, 2026
STOKSell334$31.79$11K−1.1%GENERAL COUNSEL & CORP SEC
Mar 18, 2026
STOKSell72$32.85$2K−0.2%GENERAL COUNSEL & CORP SEC
Mar 17, 2026
STOKSell1,791$33.38$60K−5.1%GENERAL COUNSEL & CORP SEC
Mar 17, 2026
STOKSell2,476$32.74$81K−6.6%GENERAL COUNSEL & CORP SEC
Dec 8, 2025
STOKSell1,300$31.60$41K−8.2%GENERAL COUNSEL & CORP SEC
Dec 8, 2025
STOKSell2,678$32.61$87K−18.5%GENERAL COUNSEL & CORP SEC
Dec 5, 2025
STOKSell5,437$31.08$169K−23.0%GENERAL COUNSEL & CORP SEC
Dec 5, 2025
STOKSell1,004$31.33$31K−4.1%GENERAL COUNSEL & CORP SEC
Dec 5, 2025
STOKSell2,344$31.76$74K−12.9%GENERAL COUNSEL & CORP SEC
Dec 4, 2025
STOKSell824$30.76$25K−3.2%GENERAL COUNSEL & CORP SEC
Dec 4, 2025
STOKSell194$31.32$6K−0.8%GENERAL COUNSEL & CORP SEC
Dec 3, 2025
STOKSell898$30.34$27K−4.1%GENERAL COUNSEL & CORP SEC
Dec 3, 2025
STOKSell1,394$30.85$43K−6.6%GENERAL COUNSEL & CORP SEC
Dec 2, 2025
STOKSell1,416$29.56$42K−5.9%GENERAL COUNSEL & CORP SEC
Dec 2, 2025
STOKSell868$30.14$26K−3.8%GENERAL COUNSEL & CORP SEC
Oct 3, 2025
STOKSell10,000$25.07$251K−45.8%GENERAL COUNSEL & CORP SEC
Sep 3, 2025
STOKSell6,345$20.07$127K−34.9%GENERAL COUNSEL & CORP SEC
Sep 2, 2025
STOKSell14,922$20.14$300K−45.1%GENERAL COUNSEL & CORP SEC
Aug 29, 2025
Filed 3d late
STOKSell850$20.00$17K−3.4%GENERAL COUNSEL & CORP SEC
Aug 18, 2025
STOKSell1,683$18.24$31K−6.6%GENERAL COUNSEL & CORP SEC
Aug 13, 2025
STOKSell13,712$15.00$206K−41.1%GENERAL COUNSEL & CORP SEC

Top Companies Traded

TICKERCOMPANYTRADESTOTAL VOLUME
STOKStoke Therapeutics, Inc.24$2.1M

Other insiders at Stoke Therapeutics, Inc.

5 other tracked filers at STOK.